Cost utility of sequential adjuvant trastuzumab for HER2/Neu-positive breast cancer.
Journal Article
Full Text
Duke Authors
Cited Authors
- Reed, SD; Schulman, KA
Published Date
- July 2009
Published In
Volume / Issue
- 12 / 5
Start / End Page
- 637 - 640
PubMed ID
- 19473336
Pubmed Central ID
- 19473336
Electronic International Standard Serial Number (EISSN)
- 1524-4733
Digital Object Identifier (DOI)
- 10.1111/j.1524-4733.2009.00564.x
Language
- eng
Conference Location
- United States